Besides, the dysregulation of anoikis-related signaling pathways, such as the PI3K/Akt and MAPK pathways, has been implicated in the enhanced invasiveness of HCC tumor cells and could render patients’ resistance to chemo- and immunotherapies (17, 18). The gene discussed is AKT1; the disease is hepatocellular carcinoma.